Skip to content
← Back to this collection

PUBLICATIONS · 20567020

IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplication.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2010 Aug 1
First author
Paschka P

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Paschka P
      type
      Author
    2. name
      Schlenk RF
      type
      Author
    3. name
      Gaidzik VI
      type
      Author
    4. name
      Habdank M
      type
      Author
    5. name
      Krönke J
      type
      Author
    6. name
      Bullinger L
      type
      Author
    7. name
      Späth D
      type
      Author
    8. name
      Kayser S
      type
      Author
    9. name
      Zucknick M
      type
      Author
    10. name
      Götze K
      type
      Author
    11. name
      Horst HA
      type
      Author
    12. name
      Germing U
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Paschka P
      type
      Author
    2. name
      Schlenk RF
      type
      Author
    3. name
      Gaidzik VI
      type
      Author
    4. name
      Habdank M
      type
      Author
    5. name
      Krönke J
      type
      Author
    6. name
      Bullinger L
      type
      Author
    7. name
      Späth D
      type
      Author
    8. name
      Kayser S
      type
      Author
    9. name
      Zucknick M
      type
      Author
    10. name
      Götze K
      type
      Author
    11. name
      Horst HA
      type
      Author
    12. name
      Germing U
      type
      Author
    bibliography ids
    1. nci-bib-1214cab1658546d11614dcf0
    book metadata
    content sha256
    40032aabb392bca027dba8b00b37c1cb66599133ba67cceaf465a5a4aff1f28d
    document type
    citation
    dois
    1. 10.1200/JCO.2010.28.3762
    electronic publication date
    display
    2010 Jun 21
    precision
    day
    year
    2010
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:20567020
    immutable id
    pubmed:20567020@40032aabb392bca027dba8b00b37c1cb66599133ba67cceaf465a5a4aff1f28d
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    22
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    3636-43
    volume
    28
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      20567020
      provenance
      batch id
      bce21fa556c206e375c2
      provider
      NCBI PubMed ESummary
      record sha256
      c1221a855a006142f10c9a085473a2e19c769730c8dc81e28932c038b4b02426
      response sha256
      280642fcc56e65c443f5ee9e69c6371de9e91c70665c7390bba25595a34da323
      retrieved at
      2026-09-09T23:46:33.526275+00:00
      publication date
      display
      2010 Aug 1
      precision
      day
      year
      2010
      publication types
      1. Journal Article
      2. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/20567020/
      title
      IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplication.

      Preserved source evidence · Independent clinical review pending · Not medical advice